Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoproliferative Disorders × Interferon-alpha × Clear all

Sponsor

Conditions

Melanoma 4 Carcinoma, Renal Cell 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Kidney Neoplasms 3 Pancreatic Neoplasms 2 Multiple Myeloma 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia 2 Warts 1 Small Cell Lung Carcinoma 1 Recurrence 1 Papilloma 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Lung Neoplasms 1 HIV Infections 1 Colorectal Neoplasms 1 Acquired Immunodeficiency Syndrome 1

Interventions

blinatumomab 6 Tacrolimus 3 Rituximab 3 Cyclophosphamide 3 ponatinib 2 fludarabine 2 Vorinostat 2 Vincristine 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Methotrexate 2 Everolimus 2 Etoposide 2 Doxorubicin 2 Darbepoetin alfa 2 Busulfan 2 Brentuximab Vedotin 2 Antilymphocyte Serum 2 tetulomab tetraxetan lu-177 1 ruxolitinib 1 pegaspargase 1 ibritumomab tiuxetan 1 fludarabine phosphate 1 ferrous sulfate 1 ferric gluconate 1 denileukin diftitox 1 cobomarsen 1 asparaginase erwinia chrysanthemi recombinant 1 Tomography, X-Ray Computed 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡